Publications by authors named "Lievin Izie Bozama"
Acute malnutrition (AM) causes large loss of life and disability in children in Africa. Researchers are testing innovative approaches to increase efficiency of treatment programs. This paper presents results of a cost-effectiveness analysis of one such program in the Democratic Republic of the Congo (DRC) based on a secondary analysis of a randomized controlled trial Optimizing Treatment for Acute Malnutrition (OptiMA), conducted in DRC in 2018-20.
View Article and Find Full Text PDFBackground: Current standard management of severe acute malnutrition uses ready-to-use therapeutic food (RUTF) at a single weight-based calculation resulting in an increasing amount of RUTF provided to the family as the child's weight increases during recovery. Using RUTF at a gradually reduced dosage as the child recovers could reduce costs while achieving similar growth response.
Methods: We conducted an open-label, non-inferiority, randomised controlled trial in the Democratic Republic of the Congo.
Background: Global access to acute malnutrition treatment is low. Different programmes using different nutritional products manage cases of severe acute malnutrition and moderate acute malnutrition separately. We aimed to assess whether integrating severe acute malnutrition and moderate acute malnutrition treatment into one programme, using a single nutritional product and reducing the dose as the child improves, could achieve similar or higher individual efficacy, increase coverage, and minimise costs compared with the current programmes.
View Article and Find Full Text PDFArticle Synopsis
- The study focuses on optimizing the treatment of acute malnutrition (AM) in children by comparing a simplified approach (OptiMA) with standard nutritional protocols, particularly targeting children aged 6-59 months with specific malnutrition criteria.
- It was conducted as a non-inferiority clinical trial in the Democratic Republic of Congo, assessing the effectiveness of the OptiMA treatment over a six-month period.
- Ethics approvals were secured from relevant health committees to ensure the study met ethical standards during its execution.